Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

113results about How to "Acceptable level" patented technology

Pooling callers for matching to agents based on pattern matching algorithms

Methods and systems are provided for routing callers to agents in a call-center routing environment. An exemplary method includes identifying caller data for at least one of a set of callers on hold and causing a caller of the set of callers to be routed to an agent based on a comparison of the caller data and the agent data. The caller data and agent data may be compared via a pattern matching algorithm and / or computer model for predicting a caller-agent pair having the highest probability of a desired outcome. As such, callers may be pooled and routed to agents based on comparisons of available caller and agent data, rather than a conventional queue order fashion. If a caller is held beyond a hold threshold the caller may be routed to the next available agent. The hold threshold may include a predetermined time, “cost” function, number of times the caller may be skipped by other callers, and so on.
Owner:AFINITI LTD

Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds

The present invention relates to a novel photoresist composition that can be developed with an aqueous alkaline solution, and is capable of being imaged at exposure wavelengths in the deep ultraviolet. The invention also relates to a process for imaging the novel photoresist as well as novel photoacid generators.The novel photoresist comprises a) a polymer containing an acid labile group, and b) a novel mixture of photoactive compounds, where the mixture comprises a lower absorbing compound selected from structure 1 and 2, and a higher absorbing compound selected from structure 4 and 5, where, R1 and R2 R5, R6, R7, R8, and R9 are defined herein; m=1–5; X− is an anion, and Ar is selected from naphthyl, anthracyl, and structure 3, where R30, R31, R32, R33, and R34 are defined herein.
Owner:MERCK PATENT GMBH

Safety air bag inflation device

An air bag inflator providing a source of gas, releasable upon command, to inflate a supplemental inflation restraint (SIR) system commonly known as an automobile air bag. Provided is a pressure vessel containing one or more separate chambers for the purpose of storing gaseous fuel(s) and gaseous oxidizer(s) or liquid fuel(s) and liquid oxidizer(s) under pressure with helium as the primary filler gas. The primary function of the helium gas is to serve as a kinetic damper to modulate and control the reaction rate of the fuel(s) and oxidizer(s). Because of its low mass, high thermal conductivity and high heat capacity for its mass, helium is an excellent filler gas. In the case of the gaseous fuel(s) and oxidizer(s) a single chamber is provided. In the case of liquid fuel(s) and oxidizer(s), two or more separate housings are provided for storing the liquid fuel(s) and oxidizer(s). Along with the liquid fuel(s) and oxidizer(s) housings, two separate chambers containing pressurized helium are provided within the pressure vessel. The first helium chamber rapidly pressurizes upon initiation of a gas producing pyrotechnic igniter. This pressure acts on thin membranes on the first chamber side of the separate liquid storage housings to force the liquid fuel(s) and oxidizer(s) into the second chamber where the materials are atomized and mixed. The mixture is ignited by the arrival of hot gases from the igniter directed into the second chamber via the small diameter tube or orifice. The fuel(s) oxidizer(s) mixture burns to produce gaseous reaction products that are released into the air bag by bursting a controlled rupture burst disc.
Owner:AUTOLIV DEV AB

Intravenous immunoglobulin composition

A method for preparing a concentrated, immunoglobulin composition for treating subjects vaccinated against or infected with a pathogenic microorganism, comprising: (a) selecting a population of individuals previously vaccinated against one or more antigens associated with the pathogenic microorganism; (b) determining the level of specific antibodies immunoreactive with the pathogenic microorganism in a blood or blood component of the individuals to identify very high titre individuals having a very high titre of the specific antibodies; (c) combining blood or blood components comprising immunoglobulins from the very high titre individuals; and (d) purifying and / or concentrating the product of step (c), thereby obtaining a concentrated immunoglobulin composition. Also disclosed is a concentrated immunoglobulin composition comprising specific antibodies immunoreactive with a pathogenic microorganism, characterized in that the titre of specific antibodies of the composition is at least 5 times higher than the average titre of specific antibodies of a population of individuals previously vaccinated against one or more antigens associated with the pathogenic microorganism. The composition has a relatively high protein concentration and a low percentage of protein aggregates, and is therefore suitable for both iv and im administration. In a preferred embodiment, the pathogenic microorganism is smallpox virus or vaccinia virus.
Owner:OMRIX BIOPHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products